It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.
In our In the Spotlight stories, Herald-Leader journalists bring you continuing coverage of news and events important to our Central Kentucky community. Read more. Story idea?